Platelet and soluble CD40L in meningococcal sepsis

Related Experiment Video

Updated: Aug 7, 2026

Humanized Mouse Model to Study Bacterial Infections Targeting the Microvasculature
11:40

Humanized Mouse Model to Study Bacterial Infections Targeting the Microvasculature

Published on: April 1, 2014

David P Inwald1, Saul N Faust, Paula Lister

  • 1Department of Paediatrics, Faculty of Medicine, Imperial College of Science, Technology & Medicine, St Mary's Campus, W2 1PG, London, UK. David.Inwald@st-marys.nhs.uk

Intensive Care Medicine
|July 1, 2006
PubMed

Insights

Elevated soluble CD40L (sCD40L) in meningococcal sepsis suggests platelet release, but surface-bound CD40L and endothelial CD40 expression were not significantly altered. Further research is needed to clarify platelet CD40L

Area of Science:

  • Immunology
  • Pediatric Critical Care
  • Hematology

Background:

  • Meningococcal sepsis (MCS) is a severe infection with significant morbidity and mortality.
  • CD40 ligand (CD40L) plays a role in immune responses and thrombosis.
  • Understanding CD40L's role in MCS is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the influence of meningococcal sepsis on platelet-derived CD40L and endothelial CD40 expression.
  • To correlate sCD40L levels with disease severity and platelet counts in children with MCS.

Main Methods:

  • Prospective observational study in pediatric intensive care units.
  • Plasma sCD40L levels measured by ELISA in 49 children with MCS and 10 controls.
  • Flow cytometry assessed membrane-bound CD40L and CD62P on platelets from 11 patients and 10 controls.
  • Immunohistochemistry examined endothelial CD40 expression in skin biopsies from six patients.

Main Results:

  • Significantly higher plasma sCD40L levels were observed in children with MCS compared to controls.
  • No correlation was found between plasma sCD40L levels and platelet count or disease severity.
  • Platelet surface-bound CD40L and CD62P levels were similar in patients and controls.
  • Endothelial CD40 expression remained preserved at sites of microthrombus formation in MCS patients.

Conclusions:

  • Elevated sCD40L in meningococcal sepsis likely originates from platelets, but its clinical significance is unclear.
  • Platelet surface CD40L does not appear to be directly involved in the pathogenesis of MCS.
  • Further studies are required to elucidate the precise role of platelet CD40L in MCS-associated inflammation and thrombosis.
Abstract

More Related Videos

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery10:03

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

Related Concept Videos

Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...